Hyphen BioMed Literature
Product Price Catalogue
Interactive Poster(s)
Blood Coagulation Poster
HEMOCLOT
HEMOCLOT - Schemes
Direct Thrombin Inhibitors
- Dabigatran Calibrator and Control Plasmas for Drug Measurement in Plasma, When Required (Ref. A222801, A224701)
Author: J. Amiral, M. Peyrafitte - HYPHEN BioMed & Stangier J. - Boehringer Ingelheim Pharma Gmbh & Co KG, GTH - February 2011
- Interference of Routine Coagulation Tests with the New Oral Anticoagulant Dabigatran - A Multicenter Study. (Ref. A222801, A224701)
Author: Weigel G., Loacker L.J. , Griesmacher A. , Tomasits J, Halbmayer W.M., Quehenberger P., Aspöck G., Haushofer A., 2011
- New Assays for Measuring Direct Thrombin Inhibitors in Plasma (Ref. ACK002K, ACK002L, ASC030K, ASC035K)
Author: M. Peyrafitte, A.M. Vissac, J. Amiral - HYPHEN BioMed, ISTH - July 2009
- Direct Thrombin Inhibitors' Activity Measurement in Plasma (ref. ASC030K, ASC035K, ACK002K, ACK002L, A220202)
Author: M. Peyrafitte, A.M. Vissac, J. Amiral - HYPHEN BioMed, February 2009
Protein C / Protein S and AT III Pathways
Factor V-Leiden
- Evaluation of a Novel Quantitative Assay for Factor V Leiden (Ref. ACK065K)
Author: Hickey KP, Cooper PC, Kitchen S. - Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, February 2010
- Quantitative Measurement of Factor V Leiden in Heterozygous and Homozygous Patients for the R506Q Factor V Mutation (Ref. ACK065K, ACK071, ARK009A)
Author: AM. Vissac, M. Peyrafitte, J. Amiral - HYPHEN BioMed, C. Leroy-Matheron - Lab Hémostase, GTH - February 2009
BIOPHEN
Factor VIII:C
Anti-Xa Heparin Assays
Factor IX and X
Direct Xa Inhibitors
- BIOPHEN DiXaI - For the Quantitative Determination of Direct Factor Xa Inhibitors in Plasma
Author: Kris Van Assche - Nodia, Bayer - Belgium, February 2012
- Specific and Rapid Measurement of Rivaroxaban in Plasma using a New, Dedicated, Chromogenic Assay
Author: Samama M.M., Amiral J., Guinet C., Perzborn E., Depasse F. - Hotel Dieu University Hospital, HYPHEN BioMed, Biomnis Laboratories R&D, Research, Bayer HealthCare, GTH - February 2010
- BIOPHEN DiXaI Powerpoint (Ref. A221030)
Author: Jonas Kingo - Aniara, February 2010
ZYMUTEST
ZYMUTEST - Schemes
Von Wilebrand Factor
Cross-Reactivities with Animal Proteins
HIT Assays
- Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
Authors: Johannes Oldenburg, Robert Klamroth, Florian Langer, Manuela Albisetti, Charis von Auer,
Cihan Ay, Wolfgang Korte, Rüdiger E. Scharf, Bernd Pötzsch1 Andreas Greinacher
- Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)
Authors: Johannes Thaler, Cihan Ay, Karoline V. Gleixner, Alexander W. Hauswirth, Filippo
Cacioppo, Jürgen Grafeneder, Peter Quehenberger, Ingrid Pabinger, Paul Knöbl
- ZYMUTEST HIA (IgG or IgGAM)
Author: Hyphen BioMed, October 2007
- ZYMUTEST HIA Algorithm (Ref. ARK040A)
Author: Hans G. Zwerger - CoaChrom Diagnostica - March 2013
- Antibodies to Protamine Sulfateor to its Complexes with Heparin can be the Sole Ones Identified in Some Patients with Suspicion of HIT
Author: Amiral J., Vissac A.M. - HYPHEN BioMed, GTH - February 2010
- Heterogenity of Heparin Induced Antibody Profiles in Patients Suspected of Heparin Induced Thrombocytopenia (HIT)
Author: Vissac A.M., Amiral J. - HYPHEN BioMed, GTH - February 2010
- Can We Improve Clinical Specificity for HIT Immunoassays? (Ref. ARK040A, ARK040B, ARK040C, ARK040D, ARK040E, ARK041A, ARK041D)
Author: A.M. Vissac, J. Amiral - HYPHEN BioMed, ISTH - July 2009
- Improved Clinical Specificity of Heparin Induced Thrombocytopenia Immunoassay (Ref. ARK040A, ARK040B, ARK040C, ARK040D, ARK040E)
Author: AM. Vissac, M. Peyrafitte, J. Amiral - HYPHEN BioMed, GTH - February 2009
- Association of Protamine Sulfate Antibodies with "Pseudo-HIT" in Heparin Treated Patients (Ref. ARK040A, ARK040B, ARK040C, ARK040D, ARK040E)
Author: J. Amiral, AM. Vissac - HYPHEN BioMed, GTH - February 2009
- New Approach for Detection Of Heparin Dependent Antibodies and Risk Assessment for Heparin Induced Thrombocytopenia - HIT Assays
Author: Amiral J, Peyrafitte M, Catala M, Vissac AM - HYPHEN BioMed, July 2007
- Incidence of the Various Heparin Dependent Antibody Isotypes in a Group of Patients With Heparin Induced Thrombocytopenia - HIT Assays
Author: Vissac AM, Catala M, Amiral J, - HYPHEN BioMed, July 2007
Microparticles
- Microparticles Exposing Tissue Factor in Human Plasma (Ref. A521196)
Author: Laroche M., Peyrafitte M., Vissac A.M. , Amiral J. - HYPHEN BioMed, GTH - February 2011
- The Multiple Faces of Tissue Factor Measured with Laboratory Assays (Ref. A521196, ARK035A, ARK042A)
Author: Laroche M., Peyrafitte M., Vissac A.M. , Amiral J. - HYPHEN BioMed, GTH - February 2011
- Microparticles Procoagulant Activity in Citrated Plasma (Ref. A521096)
Author: AM. Vissac, M. Peyrafitte, J. Amiral - HYPHEN BioMed, July 2007
Technical Files
Heparin Kits
Rivaroxaban
Chromogenic Kits
CEPHEN Kits
HEMOCLOT Kits
LIAPHEN
ZYMUTEST Kits
Evaluation of Hyphen BioMed Chromogenic Substrates vs Chromogenix Substrates
- Comparison of Characteristics and Performances of Thrombin Chromogenic Substrates: Hyphen BioMed CS-01(38) vs Chromogenix S2238 (Ref. A229001, A229001-100, A229001-1, A229001-5)
Author: M. Peyrafitte - HYPHEN BioMed, April 2009
- Comparison of Characteristics and Performances of FXa Chromogenic Substrate: Hyphen BioMed CS-11(22) vs Chromogenix S2222 (Ref. A229015, A229115, A229015-1, A229015-5)
Author: M. Peyrafitte - HYPHEN BioMed, April 2009
- Comparison of Characteristics and Performance of FXa Chromogenic Substrate: Hyphen BioMed CS-11(32) vs Chromogenix S2732 (Ref. A229011, A229011-100, A229011-1, A229011-5)
Author: M. Peyrafitte - HYPHEN BioMed, April 2009
- Comparison of Characteristics and Performances of FXa Chromogenic Substrate : Hyphen BioMed CS-11(65) vs Chromogenix S2765 (Ref. A229014, A229014-100, A229014-1, A229014-5)
Author: M. Peyrafitte - HYPHEN BioMed, April 2009
- Comparison of Characteristics and Performances of Activated Protein C (aPC) Chromogenic Substrate: Hyphen BioMed CS-21(66) vs Chromogenix S2366 (Ref. A229021, A229021-100, A229021-1, A229021-5)
Author: M. Peyrafitte - HYPHEN BioMed, April 2009
- Comparison of Characteristics and Performances of Plasmin/Plasminogen-SK Chromogenic Substrate: Hyphen BioMed CS-41(03) vs Chromogenix S2403 (Ref. A229041, A229041-100, A229041-1, A229041-5)
Author: M. Peyrafitte - HYPHEN BioMed, April 2009
- Comparison of Characteristics and Performances of Urokinase (uPA) Chromogenic Substrate: Hyphen BioMed CS-61(44) (Ref. A229061, A229061-100, A229061-1, A229061-5)
Author: M. Peyrafitte - HYPHEN BioMed, April 2009
- Evaluation of chromogenic substrates: Hyphen BioMed vs Chromogenix - All Substrates
Author: HYPHEN BioMed, February 2008
Industrial USP Heparin Reagents
